Stemline Therapeutics, Inc. ( STML ) was a big mover last session, as its shares rose almost 40% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $19.08 to $21.09.
In the last 30 days, the company did not witness any estimate revision, while the Zacks Consensus Estimate moved higher. Friday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Stemline currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Other better-ranked stocks in the medical sector include Gentium S.p.A ( GENT ), Emergent BioSolutions, Inc. ( EBS ) and Actelion Ltd . ( ALIOF ). All three sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>
ACTELION LTD (ALIOF): Get Free Report
EMERGENT BIOSOL (EBS): Free Stock Analysis Report
GENTIUM SPA-ADR (GENT): Free Stock Analysis Report
STEMLINE THERAP (STML): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research